Phase I trial of CymVectin to prevent cytomegalovirus infections in pregnancy in adolescents.

Trial Profile

Phase I trial of CymVectin to prevent cytomegalovirus infections in pregnancy in adolescents.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2012

At a glance

  • Drugs VCL 6365 (Primary)
  • Indications Cytomegalic inclusion disorders; Cytomegalovirus infections
  • Focus Adverse reactions
  • Sponsors Vical
  • Most Recent Events

    • 09 Feb 2012 This trial has not yet been initiated but it appears than Vical still intends to conduct it.
    • 22 Feb 2010 Status changed from not stated to not yet recruiting.
    • 22 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top